Eli Lilly weight loss pill orforglipron clears first late-stage trial

Eli Lilly weight loss pill orforglipron clears first late-stage trial

Eli Lilly’s Orforglipron Clears First Late-Stage Trial, Boosts Weight Loss Hopes April 17, 2025 Indianapolis, IN – Eli Lilly’s experimental oral weight reduction tablet, orforglipron, met its objectives within the first of seven late-stage trials, serving to Sort 2 diabetes sufferers lose 7.9% of physique weight (16 kilos) and decrease blood sugar over 40 weeks, … Read more

Trump says pharmaceutical tariffs are coming, but stocks rise

Trump says pharmaceutical tariffs are coming, but stocks rise

Trump Indicators Pharmaceutical Tariffs Are Coming, But Shares Rise in Defiance April 9, 2025 – Washington, D.C. – President Donald Trump doubled down on his commerce warfare rhetoric Tuesday night time, declaring at a Nationwide Republican Congressional Committee dinner that “main” tariffs on pharmaceutical imports are imminent, a transfer he insists will “carry drug manufacturing … Read more

Eli Lilly to release weight loss pill orforglipron trial data

Eli Lilly to release weight loss pill orforglipron trial data

Eli Lilly to Unveil Trial Data for Oral Weight Loss Drug Orforglipron [City, Date] – Pharmaceutical giant Eli Lilly is set to release highly anticipated clinical trial data for its experimental oral weight loss drug, orforglipron, as the race to dominate the booming obesity treatment market intensifies. The upcoming data could position the company as … Read more

Zepbound copycats remain online despite FDA ban 2025

Zepbound copycats remain online despite FDA ban 2025

Zepbound Copycats Persist Online Despite FDA Ban March 21, 2025 — Despite a recent ban by the U.S. Food and Drug Administration (FDA) on Zepbound, a weight loss medication linked to dangerous side effects, copies of the drug continue to surface online, raising concerns about consumer safety. The FDA’s action aimed to protect individuals from … Read more

Amgen weight loss drug MariTide starts two phase three trials

Amgen weight loss drug MariTide starts two phase three trials

The Amgen emblem is displayed exterior Amgen headquarters in Thousand Oaks, California, on Might 17, 2023. Amgen on Wednesday stated it has began two vital late-stage trials for its experimental weight reduction injection MariTide, one other step in its bid to enter the booming weight problems drug market.  “We’re delighted to share that these trials … Read more

Novo Nordisk offers discounted Wegovy through direct-to-consumer pharmacy

Novo Nordisk offers discounted Wegovy through direct-to-consumer pharmacy

Novo Nordisk’s Wegovy weight reduction drug has seen a meteoric rise in recognition. Novo Nordisk on Wednesday mentioned it’s going to provide its weight reduction drug Wegovy for lower than half of its typical value per thirty days via a brand new direct-to-consumer on-line pharmacy. The cash-pay providing is offered to thousands and thousands of … Read more